{
  "protocolSection": {
    "identificationModule": null,
    "descriptionModule": null,
    "conditionsModule": null,
    "designModule": {
      "studyType": "INTERVENTIONAL",
      "patientRegistry": false,
      "targetDuration": null,
      "phases": [
        "NA"
      ],
      "designInfo": {
        "allocation": "RANDOMIZED",
        "interventionModel": "PARALLEL",
        "interventionModelDescription": "A randomized double-blind parallel-group design was used in this placebo-controlled study. Participants were randomly assigned to receive either a single oral dose of placebo or immediate-release methylphenidate 20 mg according to a randomization schedule established by the National Institutes of Health pharmacy.",
        "primaryPurpose": "BASIC_SCIENCE",
        "observationalModel": null,
        "timePerspective": null,
        "maskingInfo": {
          "masking": "DOUBLE",
          "maskingDescription": "Placebo and methylphenidate oral doses were presented in identical-appearing capsules. Both participants and investigators were blinded to drug assignment.",
          "whoMasked": [
            "PARTICIPANT",
            "INVESTIGATOR"
          ]
        }
      },
      "enrollmentInfo": {
        "count": 50,
        "type": "ACTUAL"
      }
    },
    "armsInterventionsModule": null,
    "outcomesModule": {
      "primaryOutcomes": [
        {
          "measure": "Working memory performance accuracy",
          "description": "Response accuracy on the N-Back working memory task (1-Back and 3-Back conditions) measured as percentage of correct responses",
          "timeFrame": "During fMRI scanning session, approximately 90 minutes post drug administration"
        },
        {
          "measure": "BOLD activation in fronto-parietal control network (FPCN)",
          "description": "Blood-oxygen-level dependent (BOLD) signal changes in FPCN regions during working memory task (3-Back vs. 1-Back contrast), measured using functional MRI",
          "timeFrame": "During fMRI scanning session, approximately 90 minutes post drug administration"
        },
        {
          "measure": "BOLD activation in default mode network (DMN)",
          "description": "Blood-oxygen-level dependent (BOLD) signal changes in DMN regions during working memory task (3-Back vs. 1-Back contrast), measured using functional MRI",
          "timeFrame": "During fMRI scanning session, approximately 90 minutes post drug administration"
        }
      ],
      "secondaryOutcomes": [
        {
          "measure": "Working memory reaction time",
          "description": "Response time in milliseconds on the N-Back working memory task (1-Back and 3-Back conditions)",
          "timeFrame": "During fMRI scanning session, approximately 90 minutes post drug administration"
        },
        {
          "measure": "State anxiety levels (STAI-s)",
          "description": "State-Trait Anxiety Inventory state subscale scores assessed at three time points: immediately post drug administration (T1), 45 minutes post drug administration (T2), and immediately after scanner removal (T3)",
          "timeFrame": "T1: immediately post drug administration; T2: 45 minutes post drug administration; T3: immediately after fMRI scanning (approximately 120 minutes post drug administration)"
        },
        {
          "measure": "Subjective anxiety ratings during task",
          "description": "Self-reported anxiety ratings during the N-Back task performance in safe and threat conditions",
          "timeFrame": "During fMRI scanning session, approximately 90 minutes post drug administration"
        }
      ]
    },
    "eligibilityModule": null
  }
}